A Weekly Business Intelligence Briefing for Busy Professionals
Join 9,600+ biotech and pharma executives, investors, tech scouts, strategists, and scientists from firms like GSK, Eli Lilly, Pfizer, Amazon, Deloitte, and others.
Emerging technologies, such as artificial intelligence, are reshaping how we discover drugs, engineer biology, and build the future of healthcare.
They offer new ways to solve entrenched bottlenecks, unlock novel therapeutics, and rethink how biotech and pharma operate — from R&D to business models.
But with innovation comes noise: hype cycles, fragmented information, and rising complexity.
This newsletter helps you cut through the noise with clear, expert-driven analysis of the most important breakthroughs, startups, strategic shifts, and tools at the intersection of technology and the life sciences.
Delivered weekly. Sharp. Insightful. Built for professionals who need to stay ahead, not just stay informed.
What You'll Get Every Week
◆ Weekly Tech+Bio Highlights
A curated digest of the most important news in biotech, pharma, and life science innovation — paired with expert commentary and exclusive insights you won't find in the headlines. Delivered in a format that's sharp, actionable, and easy to read in under 10 minutes — built for busy professionals who need to stay ahead, not just caught up.
◆ Weekly Deep Dive
A focused analysis on a high-impact topic: from emerging technologies (like AI foundation models, organ-on-chips, digital pathology, brain-computer interfaces, etc.) to market trends, company landscapes, or new therapeutic platforms.
◆ Editorial Takes
Occasional editorial newsletters, with exclusive insights from industry events, interviews with KOLs, or specific company deep dives
Who Reads “Where Tech Meets Bio” Newsletter
- Over 9,600+ subscribers worldwide, including:
- Executives at top pharma and biotech companies
- Founders and operators at healthtech and AI startups
- PE & VC investors, bankers, stock traders
- Strategy teams, tech scouts, and market analysts
- Government and regulatory professionals
Popular Newsletter Issues:
Don't get buried in noise. Get the insights that help you think clearly, move faster, and make better decisions in biotech, pharma, and beyond.